Two-Year Outcomes After First- or Second-Generation Drug-Eluting or Bare-Metal Stent Implantation in All-Comer Patients Undergoing Percutaneous Coronary Intervention

Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group.

1990 • 1,310 citations

Analysis of 14 Trials Comparing Sirolimus-Eluting Stents with Bare-Metal Stents

2007 • 1,010 citations

Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis

2012 • 936 citations

Clopidogrel Use and Long-term Clinical Outcomes After Drug-Eluting Stent Implantation

2006 • 886 citations

Everolimus-Eluting versus Paclitaxel-Eluting Stents in Coronary Artery Disease

2010 • 871 citations

A Cause for Concern

2007 • 812 citations

Stent Thrombogenicity Early in High-Risk Interventional Settings Is Driven by Stent Design and Deployment and Protected by Polymer-Drug Coatings

2011 • 743 citations

Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial

2010 • 678 citations

Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting

2012 • 649 citations

Comparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary Stents

2010 • 647 citations

Comparison of an Everolimus-Eluting Stent and a Paclitaxel-Eluting Stent in Patients With Coronary Artery Disease

2008 • 580 citations

Three-Year Follow-up after Implantation of Metallic Coronary-Artery Stents

1996 • 519 citations

Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial

2012 • 442 citations

Effectiveness and Safety of Drug-Eluting Stents in Ontario

2007 • 398 citations

Comparison of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients With Native Coronary Artery Disease

2006 • 350 citations

Comparison of Angioplasty With Infusion of Tirofiban or Abciximab and With Implantation of Sirolimus-Eluting or Uncoated Stents for Acute Myocardial Infarction<subtitle>The MULTISTRATEGY Randomized Trial</subtitle>

2008 • 272 citations

Comparisons of Baseline Demographics, Clinical Presentation, and Long-Term Outcome Among Patients With Early, Late, and Very Late Stent Thrombosis of Sirolimus-Eluting Stents

2010 • 231 citations

2-Year Follow-Up of a Randomized Controlled Trial of Everolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice

2011 • 194 citations

Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial

2012 • 153 citations

Comparison of Zotarolimus-Eluting Stents With Sirolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization

2010 • 150 citations

Improved Late Clinical Safety With Zotarolimus-Eluting Stents Compared With Paclitaxel-Eluting Stents in Patients With De Novo Coronary Lesions

2010 • 109 citations

Should duration of dual antiplatelet therapy depend on the type and/or potency of implanted stent? A pre-specified analysis from the PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY (PRODIGY)

2013 • 107 citations

Randomized comparison of 6- versus 24-month clopidogrel therapy after balancing anti-intimal hyperplasia stent potency in all-comer patients undergoing percutaneous coronary intervention

2010 • 66 citations

Late Safety, Efficacy, and Cost-Effectiveness of a Zotarolimus-Eluting Stent Compared With a Paclitaxel-Eluting Stent in Patients With De Novo Coronary Lesions

2009 • 61 citations

Three-year follow-up of the MULTIcentre evaluation of Single high-dose Bolus TiRofiban versus Abciximab with Sirolimus-eluting STEnt or Bare-Metal Stent in Acute Myocardial Infarction StudY (MULTISTRATEGY)

2011 • 38 citations

Intravascular ultrasound, angioscopic and histopathological characterisation of heterogeneous patterns of restenosis after sirolimus-eluting stent implantation: insights into potential “thromborestenosis” phenomenon

2010 • 38 citations

Cited By (0)

Loading...